GlaxoSmithKline Pharma trades in green on plan to invest Rs 1,000 crore in new unit in Karnataka

10 Jul 2017 Evaluate

Glaxosmithkline Pharmaceuticals is currently trading at Rs. 2574.45, up by 0.15 points or 0.01% from its previous closing of Rs. 2574.30 on the BSE.

The scrip opened at Rs. 2565.00 and has touched a high and low of Rs. 2599.00 and Rs. 2500.00 respectively. So far 1870 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 3530.00 on 13-Jul-2016 and a 52 week low of Rs. 2309.05 on 30-May-2017.

Last one week high and low of the scrip stood at Rs. 2600.00 and Rs. 2490.00 respectively. The current market cap of the company is Rs. 21697.95 crore.

The promoters holding in the company stood at 75.00%, while Institutions and Non-Institutions held 12.18% and 12.82% respectively.

GlaxoSmithKline Pharmaceuticals is investing Rs 1,000 crore in a new state-of-the-art pharmaceutical unit located at Vemgal in state of Karnataka and is looking at enhancing its global pipeline in areas like respiratory drugs and vaccines in India.

The factory will initially supply a range of solid dose form products. The factory will commence production in 2018 and produce more than 8 billion tablets and 1 billion capsules a year.

GlaxoSmithKline Pharmaceuticals is a subsidiary of GlaxoSmithKline plc, one of the world's leading research-based pharmaceutical and healthcare companies, committed to improving the quality of human life by enabling people to do more, feel better and live longer.

Glaxosmithkline Phar Share Price

2311.50 -68.35 (-2.87%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×